4/25
10:24 am
amed
Amedisys, Inc. (NASDAQ: AMED) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $101.00 price target on the stock.
Low
Report
Amedisys, Inc. (NASDAQ: AMED) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $101.00 price target on the stock.
4/25
10:14 am
amed
Rating for AMED
Low
Report
Rating for AMED
3/26
01:56 pm
amed
Amedisys, Inc. (NASDAQ: AMED) had its "market perform" rating re-affirmed by analysts at Raymond James.
Low
Report
Amedisys, Inc. (NASDAQ: AMED) had its "market perform" rating re-affirmed by analysts at Raymond James.
3/26
01:56 pm
amed
Amedisys, Inc. (NASDAQ: AMED) had its "market perform" rating re-affirmed by analysts at Raymond James.
Low
Report
Amedisys, Inc. (NASDAQ: AMED) had its "market perform" rating re-affirmed by analysts at Raymond James.
3/26
01:21 pm
amed
Rating for AMED
Low
Report
Rating for AMED
3/26
01:21 pm
amed
Rating for AMED
Low
Report
Rating for AMED
3/25
08:05 am
amed
Rating for AMED
Low
Report
Rating for AMED
3/25
08:05 am
amed
Rating for AMED
Low
Report
Rating for AMED